Leg Ulcers Articles & Analysis
6 news found
The first asset, EpiDex®, is an autologous epidermal equivalent that provides a surgery-free approach to healing chronic venous leg ulcers (VLUs). Having previously been approved for the Swiss market, Healiva’s® acquisition of the complete product dossier should enable the rapid market re-launch of EpiDex®. ...
AOTI also proudly announces the formation of its industry leading multidisciplinary Scientific and Clinical Advisory Board (SCAB), consisting of world-renowned experts in Diabetic Foot Ulcers, Venous Leg Ulcers, Critical Limb Ischemia, Limb Salvage and Wound Care, encompassing the Podiatric Surgery, Vascular Surgery, Orthopedic Surgery, Plastic ...
EO2 Concepts announced today the release of a new, larger wound dressing for post-surgical dehiscence and large, painful leg ulcers. This new 5x7 OxySpur oxygen diffusion dressing is part of the OxyGeni System which provides a complete oxygen therapy and wound monitoring system. ...
Advanced Oxygen Therapy Inc. (AOTI) announced today that its unique multimodality Topical Wound Oxygen (TWO2) therapy was recently highlighted at multiple leading international clinical conferences across the United States and United Kingdom. AOTI participated both as a sponsor and exhibitor at these events that were conducted in a hybrid format, where attendance could be either in person, or ...
The unique multi-modality capabilities of TWO2 therapy have been proven in numerous clinical studies in both Diabetic Foot Ulcers (DFU) and Venous Leg Ulcers (VLU). A state-of-the-art Randomized Controlled Trial (RCT) published in 2020 in the clinical journal of the American Diabetes Association (ADA), Diabetes Care, not only demonstrated a ...
Especially addressing the needs of those with larger limbs, or with venous leg ulcers (VLU) being treated by conventional compression dressings (CCD) or UNNA boots, or those with diabetic foot ulcers (DFU) being offloaded using a total contact cast (TCC). ...